Remove clinical colorectal-cancer
article thumbnail

Asahi Kasei Pharma starts Phase III study of CIPN prevention therapy

Express Pharma

In some cases, reduced dosage or suspension of chemotherapy may be necessary to alleviate symptoms, leading to a clinical effect on the patient’s prognosis. After consultation with Japan’s Pharmaceuticals and Medical Devices Agency (PDMA) regarding potential clinical development, Asahi Kasei Pharma initiated the Phase III study.

article thumbnail

The MEK effect on cancer — a slow and steady approach to drug resistance

PharmaVoice

It’s human instinct to want to destroy cancer as fast as possible. Cancer is this bug. To overcome that hurdle, Immuneering is testing an approach that slows cancer down rather than rushing to destroy it. And if you can do that, cancer becomes a chronic, manageable disease, like diabetes, cardiac disease or HIV.

Immunity 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ALX Oncology’s ALX2004 gains FDA IND clearance to treat solid tumours

Pharmaceutical Business Review

Based on the FDA clearance, the company anticipates the commencement of Phase I clinical trials for ALX2004 in mid-2025. Its overexpression is associated with multiple tumour types, including colorectal carcinoma, breast cancer, non-small cell lung cancer and head and neck squamous cell carcinoma.

article thumbnail

Flu Vaccines Are a Go

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

article thumbnail

OPC 2025: Early and Metastatic GI Cancers See Practice Changing Trial Results

Pharmacy Times

At the 2025 Oncology Pharmacists Connect (OPC) meeting, Courtney Cavalieri, PharmD, BCOP, presented clinical trial findings in gastrointestinal (GI) cancers—including colon, gastric, pancreatic, and metastatic colorectal cancer—that highlight the expanding role of immunotherapy and targeted treatments.

22
article thumbnail

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

article thumbnail

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)